FDA inspection
Xinxiang Tuoxin Pharmaceutical Co. Ltd: FDA inspection ending Oct 22, 2021
FDA inspection 1155762 · Official Action Indicated (OAI) · Xinxiang
Key facts
| Inspection ID | 1155762 |
|---|---|
| Firm | Xinxiang Tuoxin Pharmaceutical Co. Ltd |
| FEI number | 3008259785 |
| Address | Xinxiang Advanced, 398 Jingquan West Road; Technology District |
| City | Xinxiang |
| Country | China |
| Fiscal year | 2022 |
| Inspection end date | Oct 22, 2021 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data